LVMI and prevalence of LVH in ARVD patients compared with control patients and stratified according to renal functional grouping
| Control Group (n = 50) | ARVD Group (n = 79) | P | |
|---|---|---|---|
| LVMI (g/m2) | |||
| preserved renal function | 101.1 ± 24.9 | 148.9 ± 45.5 | <0.05 |
| moderate renal failure | 110.8 ± 37.5 | 184.9 ± 69.8 | <0.001 |
| severe renal failure | 126.7 ± 28.0 | 188.3 ± 82.5 | <0.005 |
| P(between renal function categories) | 0.139 | 0.171 | |
| Prevalence of LVH (%) | |||
| preserved renal function | 33.3 | 68.8 | NS |
| moderate renal failure | 43.5 | 82.8 | <0.05 |
| severe renal failure | 52.4 | 78.6 | NS |
| P(between renal function categories) | 0.673 | 0.173 | |
| Cholesterol (mmol/L) | 4.4 ± 1.0 | 4.7 ± 1.1 | NS |
| Calcium-phosphate product (mmol/L) | 3.0 ± 1.0 | 2.7 ± 0.7 | NS |